Wird geladen...
Pembrolizumab on pre-existing inclusion body myositis: a case report
BACKGROUND: Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the first c...
Gespeichert in:
| Veröffentlicht in: | BMC Rheumatol |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493364/ https://ncbi.nlm.nih.gov/pubmed/32944686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00144-5 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|